Kyle Piskel - 18 Nov 2024 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Financial Officer
Signature
/s/ Kyle Piskel
Issuer symbol
ADPT
Transactions as of
18 Nov 2024
Transactions value $
-$1,235
Form type
4
Filing time
19 Nov 2024, 18:45:52
Previous filing
17 May 2024
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Sale -$1.24K -248 -0.16% $4.98 154K 18 Nov 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade.